ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) CEO Jacob Chacko sold 14,539 shares of ORIC Pharmaceuticals stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $8.58, for a total value of $124,744.62. Following the completion of the sale, the chief executive officer now directly owns 808,544 […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) CEO Jacob Chacko sold 14,539 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $8.58, for a total transaction of $124,744.62. Following the completion of the transaction, the chief executive officer now owns 808,544 […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) insider Pratik S. Multani sold 5,282 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $8.59, for a total value of $45,372.38. Following the completion of the sale, the insider now directly owns 23,809 shares […]
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Get Free Report) COO Muthusamy Shanmugam sold 13,026 shares of the firm’s stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $52.44, for a total transaction of $683,083.44. Following the sale, the chief operating officer now owns 957,620 shares of […]
StockNews.com lowered shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) from a buy rating to a hold rating in a report published on Saturday. Other analysts also recently issued reports about the stock. Cantor Fitzgerald reiterated an overweight rating and issued a $42.00 price target on shares of ACADIA Pharmaceuticals in a report on Thursday, […]